autologous peripheral blood-derived stem cell therapy (Enhance Biomedical)

N/A

Report date: 2025/03/14 16:35:50

Base Information

Drug Nameautologous peripheral blood-derived stem cell therapy (Enhance Biomedical)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Peripheral blood stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnhance Biotech
China Registration ClassN/A

Develop Information

Active CompaniesEnhance Biotech
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A